US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

8.38

-0.2716-3.14%

Volume:231.42K

Turnover:1.97M

Market Cap:384.54M

PE:-3.53

High:8.89

Open:8.71

Low:8.37

Close:8.65

52wk High:25.96

52wk Low:4.68

Shares:45.90M

Float Shares:37.58M

Volume Ratio:0.94

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3710

EPS(LYR):-2.2432

ROE:-28.21%

ROA:-18.47%

PB:1.03

PE(LYR):-3.74

Loading ...

Overview Company News Filings

BioAge Labs is Maintained at Buy by Needham

Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)

Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

BioAge Labs price target lowered to $25 from $36 at Roth Capital

Buy Rating Reaffirmed on BioAge: Sell-Off Seen as Overdone Amid Validated NLRP3 Platform and Triple-Digit Upside Potential

BioAge Labs pullback after ZEUS data ‘seems overdone,’ says Citi

BioAge Labs price target lowered at Jefferies after Novo trial miss

BioAge Labs price target lowered to $50 from $60 at Oppenheimer

BioAge Labs Down over 61%, on Pace for Largest Percent Decrease Since December 2024

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Sales of Leqembi® Totaled 29.3 Billion Yen in the Second Quarter 2026

THOMSON REUTERS

How Broad Russell Growth Index Inclusion Could Shape BioAge Labs (BIOA) Investor Exposure

Simply Wall St.

Bioage Labs Principal Accounting Officer Shane Barton Disposes of 62,566 Common Shares for $1,578,254.20

BioAge Moves BGE-102 Into Mid-Stage Obesity Heart-Risk Trial, Raising New Investor Focus

Analysts Are Bullish on These Healthcare Stocks: BioAge Labs, Inc. (BIOA), Karyopharm Therapeutics (KPTI)

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Viridian Therapeutics (VRDN)

BioAge doses first participant in Phase 2 QUELL-CV trial of NLRP3 inhibitor BGE-102

Bioage Labs - Topline Data From Quell-Cv Trial Anticipated in Second Half of 2026

THOMSON REUTERS

Bioage Labs Announces First Participant Dosed in Quell-Cv, a Phase 2 Proof-of-Concept Trial of Bge-102, a Novel Oral Nlrp3 Inhibitor, in Patients at Elevated Cardiovascular Risk

THOMSON REUTERS

Bioage Labs - to Initiate Phase 1B/2a Trial of Bge-102 in Dme in Mid-2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BIOA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":8.3784,"timestamp":1789147098990,"preClose":8.65,"halted":0,"volume":231424,"delay":0,"changeRate":-0.031398843930635974,"floatShares":37575608,"shares":45896909,"eps":-2.371024,"marketStatus":"Trading","change":-0.2716,"latestTime":"09-11 13:18:30 EDT","open":8.71,"high":8.885,"low":8.37,"amount":1966364.137472,"amplitude":0.059538,"askPrice":8.39,"askSize":700,"bidPrice":8.36,"bidSize":138,"shortable":3,"etf":0,"ttmEps":-2.371024,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":8.65,"preHourTrading":{"tag":"盘前","latestPrice":8.736,"preClose":8.65,"latestTime":"08:34 EDT","volume":526,"amount":4607.513832,"timestamp":1789130087004,"change":0.086,"changeRate":0.009942,"amplitude":0.020751},"postHourTrading":{"tag":"盘后","latestPrice":8.65,"preClose":8.65,"latestTime":"19:42 EDT","volume":6520,"amount":56400.0837,"timestamp":1789083770374,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.942251,"impliedVol":1.398,"impliedVolPercentile":0.8327},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":37575608,"roa":"-18.47%","roe":"-28.21%","lyrEps":-2.243207,"volumeRatio":0.942251,"shares":45896909,"dividePrice":0,"high":8.885,"amplitude":0.059538,"preClose":8.65,"low":8.37,"week52Low":4.68,"pbRate":"1.03","psRate":"37.14","week52High":25.955,"institutionHeld":0,"latestPrice":8.3784,"committee":-0.670644,"eps":-2.371024,"divideRate":0,"volume":231424,"delay":0,"ttmEps":-2.371024,"open":8.71,"prevYearClose":13.23,"prevWeekClose":9.59,"prevMonthClose":9.5,"prevQuarterClose":24.51,"fiveDayClose":9.5,"twentyDayClose":10.43,"sixtyDayClose":20.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"BIOA","fiscalQuarterEnding":"2026/06","expectedEps":-0.65,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-05-08","symbol":"BIOA","fiscalQuarterEnding":"2026/03","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-03-24","symbol":"BIOA","fiscalQuarterEnding":"2025/12","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774324800000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"BIOA","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-08-06","symbol":"BIOA","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.3333,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1779940800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2026-09-10","current":-3.533663,"percent":0.497951,"low":-14.88445,"twenty":-10.381823,"median":-4.361777,"eighty":-2.196994,"high":-1.532635,"avg":-5.899049,"sd":3.943758,"marketCap":420874655},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153},{"date":"2025-05-09","current":-2.073948,"twenty":-10.229442,"median":-2.420641,"eighty":-2.117456,"marketCap":147343652},{"date":"2025-05-16","current":-1.927611,"twenty":-10.158835,"median":-2.377687,"eighty":-2.112406,"marketCap":136947141},{"date":"2025-05-23","current":-2.038626,"twenty":-10.109042,"median":-2.344838,"eighty":-2.086198,"marketCap":144834149},{"date":"2025-05-30","current":-2.008349,"twenty":-10.078276,"median":-2.334731,"eighty":-2.073148,"marketCap":142683147},{"date":"2025-06-06","current":-2.24047,"twenty":-9.99928,"median":-2.314518,"eighty":-2.051746,"marketCap":159174164},{"date":"2025-06-13","current":-2.2657,"twenty":-9.918948,"median":-2.294303,"eighty":-2.064674,"marketCap":160966666},{"date":"2025-06-20","current":-2.215239,"twenty":-9.87707,"median":-2.284196,"eighty":-2.072748,"marketCap":157381662},{"date":"2025-06-27","current":-2.200101,"twenty":-9.785504,"median":-2.271562,"eighty":-2.073948,"marketCap":156306161},{"date":"2025-07-03","current":-2.159732,"twenty":-9.684587,"median":-2.26468,"eighty":-2.075591,"marketCap":153438158},{"date":"2025-07-11","current":-2.361576,"twenty":-9.665383,"median":-2.263661,"eighty":-2.08254,"marketCap":167778173},{"date":"2025-07-18","current":-2.422129,"twenty":-9.609795,"median":-2.271562,"eighty":-2.08404,"marketCap":172080177},{"date":"2025-07-25","current":-2.371668,"twenty":-9.500638,"median":-2.280838,"eighty":-2.084673,"marketCap":168495173},{"date":"2025-08-01","current":-2.220285,"twenty":-9.464253,"median":-2.280838,"eighty":-2.088197,"marketCap":157740162},{"date":"2025-08-08","current":-1.959737,"twenty":-9.314668,"median":-2.269035,"eighty":-2.084673,"marketCap":154872159},{"date":"2025-08-15","current":-2.023247,"twenty":-9.295465,"median":-2.262157,"eighty":-2.074957,"marketCap":159891165},{"date":"2025-08-22","current":-2.041393,"twenty":-9.27525,"median":-2.258928,"eighty":-2.064982,"marketCap":161325166},{"date":"2025-08-29","current":-2.177486,"twenty":-9.225726,"median":-2.244642,"eighty":-2.064982,"marketCap":172080177},{"date":"2025-09-05","current":-2.136658,"twenty":-9.156998,"median":-2.24047,"eighty":-2.068612,"marketCap":168853674},{"date":"2025-09-12","current":-2.227387,"twenty":-9.141838,"median":-2.24047,"eighty":-2.071948,"marketCap":176023681},{"date":"2025-09-19","current":-2.368016,"twenty":-8.95182,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-09-26","current":-2.368016,"twenty":-8.818412,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-10-03","current":-2.676493,"twenty":-8.732502,"median":-2.244642,"eighty":-2.078994,"marketCap":211515218},{"date":"2025-10-10","current":-2.472354,"twenty":-3.102868,"median":-2.258928,"eighty":-2.082165,"marketCap":195382701},{"date":"2025-10-17","current":-2.318115,"twenty":-3.072547,"median":-2.260654,"eighty":-2.08404,"marketCap":183193689},{"date":"2025-10-24","current":-3.606461,"twenty":-3.072547,"median":-2.2657,"eighty":-2.08404,"marketCap":285007794},{"date":"2025-10-31","current":-3.50666,"twenty":-3.483977,"median":-2.271562,"eighty":-2.087206,"marketCap":277120786},{"date":"2025-11-07","current":-3.533398,"twenty":-3.483977,"median":-2.280838,"eighty":-2.091294,"marketCap":267799776},{"date":"2025-11-14","current":-3.65216,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"marketCap":276800885},{"date":"2025-11-21","current":-4.063738,"twenty":-3.690007,"median":-2.299357,"eighty":-2.092162,"marketCap":307994767},{"date":"2025-11-28","current":-4.489508,"twenty":-3.899107,"median":-2.309042,"eighty":-2.092231,"marketCap":340264301},{"date":"2025-12-05","current":-4.967317,"twenty":-4.069415,"median":-2.318115,"eighty":-2.105866,"marketCap":376477888},{"date":"2025-12-12","current":-6.031742,"twenty":-4.3315,"median":-2.319571,"eighty":-2.109405,"marketCap":457151721},{"date":"2025-12-19","current":-5.856703,"twenty":-5.07234,"median":-2.333015,"eighty":-2.111789,"marketCap":443885358},{"date":"2025-12-26","current":-6.660935,"twenty":-5.750734,"median":-2.336346,"eighty":-2.112399,"marketCap":504838920},{"date":"2026-01-02","current":-6.258819,"twenty":-5.908741,"median":-2.336346,"eighty":-2.11442,"marketCap":474362139},{"date":"2026-01-09","current":-6.585243,"twenty":-6.05445,"median":-2.344838,"eighty":-2.11744,"marketCap":499102115},{"date":"2026-01-16","current":-10.175903,"twenty":-6.388442,"median":-2.355734,"eighty":-2.117456,"marketCap":771241845},{"date":"2026-01-23","current":-10.411813,"twenty":-6.562534,"median":-2.368016,"eighty":-2.117456,"marketCap":789121720},{"date":"2026-01-30","current":-10.521991,"twenty":-6.660935,"median":-2.37516,"eighty":-2.117837,"marketCap":797472215},{"date":"2026-02-06","current":-11.006774,"twenty":-8.674889,"median":-2.403126,"eighty":-2.119987,"marketCap":834214390},{"date":"2026-02-13","current":-10.984738,"twenty":-9.153966,"median":-2.415588,"eighty":-2.124502,"marketCap":832544291},{"date":"2026-02-20","current":-11.094916,"twenty":-9.298497,"median":-2.422129,"eighty":-2.13258,"marketCap":840894786},{"date":"2026-02-27","current":-12.295855,"twenty":-9.537248,"median":-2.429257,"eighty":-2.136658,"marketCap":931915175},{"date":"2026-03-06","current":-11.22713,"twenty":-9.787979,"median":-2.458744,"eighty":-2.147751,"marketCap":850915379},{"date":"2026-03-13","current":-10.954439,"twenty":-10.064753,"median":-2.474292,"eighty":-2.150267,"marketCap":830247905},{"date":"2026-03-20","current":-11.590717,"twenty":-10.152544,"median":-2.496444,"eighty":-2.150267,"marketCap":878472010},{"date":"2026-03-27","current":-8.946976,"twenty":-10.175903,"median":-2.526002,"eighty":-2.154686,"marketCap":721170986},{"date":"2026-04-02","current":-9.761839,"twenty":-10.157216,"median":-2.545959,"eighty":-2.157168,"marketCap":786853020},{"date":"2026-04-10","current":-9.794874,"twenty":-10.109042,"median":-2.572155,"eighty":-2.15903,"marketCap":789515805},{"date":"2026-04-17","current":-9.354407,"twenty":-10.088448,"median":-2.581791,"eighty":-2.159654,"marketCap":754012003},{"date":"2026-04-24","current":-9.492053,"twenty":-10.157216,"median":-2.612676,"eighty":-2.159732,"marketCap":765106941},{"date":"2026-05-01","current":-9.281102,"twenty":-10.117474,"median":-2.677432,"eighty":-2.159732,"marketCap":748103216},{"date":"2026-05-08","current":-9.815385,"twenty":-10.117474,"median":-2.685566,"eighty":-2.162275,"marketCap":791169098},{"date":"2026-05-15","current":-9.250894,"twenty":-10.100274,"median":-2.711219,"eighty":-2.168441,"marketCap":831932916},{"date":"2026-05-22","current":-8.274644,"twenty":-10.088448,"median":-2.728907,"eighty":-2.172379,"marketCap":744138767},{"date":"2026-05-29","current":-8.427879,"twenty":-10.073417,"median":-2.779442,"eighty":-2.173018,"marketCap":757919114},{"date":"2026-06-05","current":-8.413049,"twenty":-10.064858,"median":-2.893147,"eighty":-2.175699,"marketCap":756585532},{"date":"2026-06-12","current":-8.131296,"twenty":-9.999175,"median":-2.971476,"eighty":-2.177486,"marketCap":731247474},{"date":"2026-06-18","current":-9.881131,"twenty":-10.021034,"median":-3.072547,"eighty":-2.177486,"marketCap":888610152},{"date":"2026-06-26","current":-11.18115,"twenty":-10.10449,"median":-3.377371,"eighty":-2.17969,"marketCap":1005520843},{"date":"2026-07-02","current":-11.991808,"twenty":-10.16483,"median":-3.4182,"eighty":-2.183022,"marketCap":1078423326},{"date":"2026-07-10","current":-12.30322,"twenty":-10.247258,"median":-3.447686,"eighty":-2.183492,"marketCap":1106428549},{"date":"2026-07-17","current":-10.953771,"twenty":-10.359979,"median":-3.495318,"eighty":-2.185281,"marketCap":985072585},{"date":"2026-07-24","current":-10.825252,"twenty":-10.509871,"median":-3.543352,"eighty":-2.186883,"marketCap":973514874},{"date":"2026-07-31","current":-12.283448,"twenty":-10.632169,"median":-3.606461,"eighty":-2.188179,"marketCap":1104650439},{"date":"2026-08-07","current":-5.30342,"twenty":-10.612701,"median":-3.697103,"eighty":-2.190009,"marketCap":500982312},{"date":"2026-08-14","current":-5.067589,"twenty":-10.521991,"median":-3.898161,"eighty":-2.190009,"marketCap":478704760},{"date":"2026-08-21","current":-4.708048,"twenty":-10.461393,"median":-3.973853,"eighty":-2.193232,"marketCap":444741048},{"date":"2026-08-28","current":-4.897536,"twenty":-10.411813,"median":-4.092123,"eighty":-2.193232,"marketCap":462640842},{"date":"2026-09-04","current":-4.615733,"twenty":-10.411209,"median":-4.290815,"eighty":-2.195055,"marketCap":436020635},{"date":"2026-09-10","current":-4.455397,"twenty":-10.381823,"median":-4.361777,"eighty":-2.196994,"marketCap":420874655}],"updateTime":1789147110048},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656391865","title":"BioAge Labs is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391865?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:17","pubTimestamp":1785529020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656439571","title":"Roth MKM Reaffirms Their Buy Rating on BioAge Labs, Inc. (BIOA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656439571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656439571?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:55","pubTimestamp":1785524130,"startTime":"0","endTime":"0","summary":"In a report released today, Adam Walsh from Roth MKM maintained a Buy rating on BioAge Labs, Inc., with a price target of $25.00. According to TipR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-bioage-labs-inc-bioa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-reaffirms-their-buy-rating-on-bioage-labs-inc-bioa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395746","title":"Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395746?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:50","pubTimestamp":1785523843,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (GLUE) is trading lower after Novo Nordisk’s (NVO) ZEUS trial failed to show a cardiovascular benefit for IL 6 inhibition, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/monte-rosa-bioage-sink-following-novo-nordisks-zeus-setback-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/monte-rosa-bioage-sink-following-novo-nordisks-zeus-setback-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","LU1093756168.USD","BK4585","NVO","BK4539","BK4139","LU1093756325.SGD","NVOH","BK4588","NVOX","PPH","GLUE","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","BK4007","IE00BZ1G4Q59.USD","THNR","BK4599","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395127","title":"BioAge Labs price target lowered to $25 from $36 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395127?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:40","pubTimestamp":1785523222,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Adam Walsh lowered the firm’s price target on BioAge Labs (BIOA) to $25 from $36 and keeps a Buy rating on the shares after No...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-price-target-lowered-to-25-from-36-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-price-target-lowered-to-25-from-36-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395120","title":"Buy Rating Reaffirmed on BioAge: Sell-Off Seen as Overdone Amid Validated NLRP3 Platform and Triple-Digit Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395120?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:36","pubTimestamp":1785522962,"startTime":"0","endTime":"0","summary":"Analyst Samantha Semenkow of Citi maintained a Buy rating on BioAge Labs, Inc., with a price target of $52.00. Samantha Semenkow has given his Buy ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-bioage-sell-off-seen-as-overdone-amid-validated-nlrp3-platform-and-triple-digit-upside-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-bioage-sell-off-seen-as-overdone-amid-validated-nlrp3-platform-and-triple-digit-upside-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656393241","title":"BioAge Labs pullback after ZEUS data ‘seems overdone,’ says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2656393241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656393241?lang=en_us&edition=fundamental","pubTime":"2026-08-01 01:40","pubTimestamp":1785519623,"startTime":"0","endTime":"0","summary":"Citi notes that BioAge Labs (BIOA) shares are down greater than 60% following the news that Novo Nordisk’s (NVO) ZEUS trial for ziltivekimab failed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-pullback-after-zeus-data-seems-overdone-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-pullback-after-zeus-data-seems-overdone-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656393225","title":"BioAge Labs price target lowered at Jefferies after Novo trial miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2656393225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656393225?lang=en_us&edition=fundamental","pubTime":"2026-08-01 01:30","pubTimestamp":1785519033,"startTime":"0","endTime":"0","summary":"Jefferies lowered the firm’s price target on BioAge Labs (BIOA) to $21 from $62 and keeps a Buy rating on the shares, stating that the “outright MA...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-price-target-lowered-at-jefferies-after-novo-trial-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-price-target-lowered-at-jefferies-after-novo-trial-miss-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656932263","title":"BioAge Labs price target lowered to $50 from $60 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2656932263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656932263?lang=en_us&edition=fundamental","pubTime":"2026-08-01 01:25","pubTimestamp":1785518712,"startTime":"0","endTime":"0","summary":"Oppenheimer lowered the firm’s price target on BioAge Labs (BIOA) to $50 from $60 and keeps an Outperform rating on the shares. Published first on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-price-target-lowered-to-50-from-60-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-price-target-lowered-to-50-from-60-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","BIOA","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656935253","title":"BioAge Labs Down over 61%, on Pace for Largest Percent Decrease Since December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2656935253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656935253?lang=en_us&edition=fundamental","pubTime":"2026-08-01 01:03","pubTimestamp":1785517380,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc.  is currently at $9.61, down $15.24 or 61.33%--Would be lowest close since Dec. 3, 2025, when it closed at $9.22--On pace for largest percent decrease since Dec. 9, 2024, when it fell 76.85%--Snaps a three day winning streak--Down 55.86% this week; worst weekly performance since the week ending Dec. 13, 2024, when it fell 78.70%--Down 60.79% month-to-date; on pace for worst month since Dec. 2024, when it fell 69.2%--Down 27.36% year-to-date--Down 62.8% from its all-time closing high of $25.83 on Oct. 21, 2024--Up 133.25% from 52 weeks ago , when it closed at $4.12--Down 61.71% from its 52-week closing high of $25.10 on July 2, 2026--Up 133.25% from its 52-week closing low of $4.12 on Aug. 1, 2025--Traded as low as $8.65; lowest intraday level since Dec. 3, 2025, when it hit $8.49--Down 65.19% at today's intraday low; largest intraday percent decrease since Dec. 9, 2024, when it fell as much as 77.6%All data as of 1:00:39 PM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655462358","title":"U.S. Research ROUNDUP-Apple, Amazon, Mastercard","url":"https://stock-news.laohu8.com/highlight/detail?id=2655462358","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655462358?lang=en_us&edition=fundamental","pubTime":"2026-07-31 15:13","pubTimestamp":1785482003,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Apple, Amazon, MastercardJuly 31 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including, Apple, Amazon and M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X0NJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COWG","OWL","AMP","BLDR","GNMX","SMHX","WHD","AGCO","AMCX","AR","AXSM","BMY","BCYC","MACW.SI","AXTI","AJG","BDC","BIOA","VT","AWK","ALNY","BOH","AX","BELFB","AEP","AMZN","ALRS","LABX","LAZR","IBAT","ARXS","BHRB","AVY","AOS","APD","AAPL","AZYY","ASH","BFAM","BJRI","VGT","BSX","AQMS","FDMT","BXMT","ALAB","BAX","POW","ALGM","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655869917","title":"Sales of Leqembi® Totaled 29.3 Billion Yen in the Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655869917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655869917?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:30","pubTimestamp":1785321058,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUAFLZS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650045459","title":"How Broad Russell Growth Index Inclusion Could Shape BioAge Labs (BIOA) Investor Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2650045459","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650045459?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:22","pubTimestamp":1783650160,"startTime":"0","endTime":"0","summary":"In late June 2026, BioAge Labs, Inc. (NasdaqGS:BIOA) was added to multiple Russell Growth Benchmark Indexes, including the Russell 2000, Russell 2500, Russell 3000, Russell 3000E, Russell Microcap, and the Russell Small Cap Comp Growth indexes.\nThis broad index inclusion significantly expands BioAge Labs’ visibility among institutional investors and index-tracking funds that follow these Russell Growth benchmarks.\nNext, we’ll examine how BioAge Labs’ broad Russell Growth index inclusion...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/how-broad-russell-growth-index-inclusion-could-shape-bioage","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/how-broad-russell-growth-index-inclusion-could-shape-bioage","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648262115","title":"Bioage Labs Principal Accounting Officer Shane Barton Disposes of 62,566 Common Shares for $1,578,254.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2648262115","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648262115?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:27","pubTimestamp":1782937665,"startTime":"0","endTime":"0","summary":"BioAge Labs principal accounting officer Shane Barton disposes of 62,566 common shares for $1,578,254.20BioAge Labs principal accounting officer Shane Barton sold 62,566 shares on June 29-30, ending w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL7chPKv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bioage Labs Principal Accounting Officer Shane Barton Disposes of 62,566 Common Shares for $1,578,254.20","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644080138","title":"BioAge Moves BGE-102 Into Mid-Stage Obesity Heart-Risk Trial, Raising New Investor Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2644080138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644080138?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:32","pubTimestamp":1781800375,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc. ($BIOA) announced an update on their ongoing clinical study. BioAge Labs, Inc. has launched a Phase 2 trial titled “A Phase 2, Ra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioage-moves-bge-102-into-mid-stage-obesity-heart-risk-trial-raising-new-investor-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioage-moves-bge-102-into-mid-stage-obesity-heart-risk-trial-raising-new-investor-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644741614","title":"Analysts Are Bullish on These Healthcare Stocks: BioAge Labs, Inc. (BIOA), Karyopharm Therapeutics (KPTI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644741614","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644741614?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:30","pubTimestamp":1781703053,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioAge Labs, Inc. (BIOA), Karyopharm Therapeutics (K...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-bioage-labs-inc-bioa-karyopharm-therapeutics-kpti-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-bioage-labs-inc-bioa-karyopharm-therapeutics-kpti-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4139","KPTI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644748499","title":"Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644748499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644748499?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:00","pubTimestamp":1781694034,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on BioAge Labs, Inc. (BIOA) and Viridian Therapeutics (VRDN) with neutral ratings, indicating that the e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","BK4137","VRDN","LU0029874061.USD","XLV","LABU","HCSG","BK4585","BK4588","LU0128526141.USD","BIOA","BK4007","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643752300","title":"BioAge doses first participant in Phase 2 QUELL-CV trial of NLRP3 inhibitor BGE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2643752300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643752300?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:16","pubTimestamp":1781612195,"startTime":"0","endTime":"0","summary":"BioAge Labs dosed the first participant in QUELL-CV, a Phase 2 trial of oral NLRP3 inhibitor BGE-102 for cardiovascular risk reduction.Study will test three once-daily doses versus placebo in 160 adults with obesity and elevated inflammation.Readout will assess whether BGE-102 lowers systemic inflammation, guiding dose selection for a planned Phase 3 program.Phase 1 results were previously reported, showing the drug reduced inflammation and was well tolerated.Topline Phase 2 data are expected in the second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief on June 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4npzzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643754046","title":"Bioage Labs - Topline Data From Quell-Cv Trial Anticipated in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643754046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643754046?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUABNWHLK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643480754","title":"Bioage Labs Announces First Participant Dosed in Quell-Cv, a Phase 2 Proof-of-Concept Trial of Bge-102, a Novel Oral Nlrp3 Inhibitor, in Patients at Elevated Cardiovascular Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2643480754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643480754?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUABNWHLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643375404","title":"Bioage Labs - to Initiate Phase 1B/2a Trial of Bge-102 in Dme in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643375404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643375404?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUABNWHLK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":100,"code":"91000000","status":"200"}]}}